Our research is driven by a clear purpose: to reduce the impact of asbestos and dust-related diseases on workers, families, and communities. Through evidence-led research across laboratory discovery, clinical care and public health, we are improving screening, supporting earlier and less invasive diagnosis, and advancing more effective treatment approaches. By addressing these critical areas, we’re working towards a future where the devastating impact of asbestos and dust-related diseases is significantly reduced, if not eliminated entirely.
“Having a clinical element to ADDRI means that we can be involved in changes that will actually impact not only on the patients now, but the next generation of patients with mesothelioma.” – A/Prof Anthony Linton, Medical Oncologist, ADDRI Academic and Research Director.